Can peripheral leukocytes be used as Alzheimer’s disease biomarkers?
- 1 November 2009
- journal article
- review article
- Published by Taylor & Francis in Expert Review of Neurotherapeutics
- Vol. 9 (11) , 1623-1633
Abstract
(2009). Can peripheral leukocytes be used as Alzheimer’s disease biomarkers? Expert Review of Neurotherapeutics: Vol. 9, No. 11, pp. 1623-1633.Keywords
This publication has 134 references indexed in Scilit:
- Natural killer cells remember: An evolutionary bridge between innate and adaptive immunity?European Journal of Immunology, 2009
- Neuroprotective natural antibodies to assemblies of amyloidogenic peptides decrease with normal aging and advancing Alzheimer's diseaseProceedings of the National Academy of Sciences, 2009
- Anti-RAGE and A Immunoglobulin Levels Are Related to Dementia Level and Cognitive PerformanceThe Journals of Gerontology, Series A: Biological Sciences and Medical Sciences, 2009
- Blocking TGF-β–Smad2/3 innate immune signaling mitigates Alzheimer-like pathologyNature Medicine, 2008
- Immunophenotypes in the circulation of patients with mild cognitive impairmentJournal of Psychiatric Research, 2008
- Prevalence of Dementia in the United States: The Aging, Demographics, and Memory StudyNeuroepidemiology, 2007
- Innate immunity and transcription of MGAT-III and Toll-like receptors in Alzheimer's disease patients are improved by bisdemethoxycurcuminProceedings of the National Academy of Sciences, 2007
- Biomarkers and surrogate endpoints: Preferred definitions and conceptual frameworkClinical Pharmacology & Therapeutics, 2001
- Reduced natural killer cell activity in patients with dementia of the Alzheimer typeActa Neurologica Scandinavica, 1991
- Aging: A Theory Based on Free Radical and Radiation ChemistryJournal of Gerontology, 1956